Yes, I would definitely switch, I am guessing at some point most of us will because of insurance. Now wanting to switch and being made it switch that may be two different things.
I live in Canada and have been on Inflectra the biosimilar to Remicade for one year. I had been on Cimzia injections successfully for 4years til Cimzia began losing its efffect and I was declining. The studies and succcess of Inflectra were explained to me in detail by my Doctor and I decided to try it. So far, the results have been successful for me and my symptoms are now back under control. I always research new drugs before introducing them to my body and I was surprised at the length of time Inflectra has successfullly been in use in Europe. I am lucky our health care covers all drugs especially when taking Cimzia as it was approx $3500.00 per month and therefore because the biosimilars are very very much less expensive, the good old drug companies would fight biosimillars as a competitor. Sadly, the patients are not seen as sufffering humans as in the drug industry, we are dollar signs. I hope you do the research and try Inflectra if offered when you need change
I agree with Laura.
It doesn’t matter two hoots what you or I think.
It will all be controlled by the goverment(s) and
the insurance companies. Unfortunately this is another
disinsentive for drug companies to continue to develop
new biologics which is what we really need done as
one after another biologic loses its effectiveness for us.
Thank you for explaining “biosimilars”. It is a very helpful article.
I noticed “relief” within 8 weeks of taking Cimzia. Swelling decreased in my hands and very little morning stiffness. Had to make the switch from Rituxan which was not slowing the progression. Good luck!
I live in Germany and switched to Benepali, the biosimilar of Enbrel. Good news: I had less skin reaction at the injection point where Enbrel caused itching and reddness, while its biosimilar caused no skin reaction. The conservational fluid might be different (which can be an asset in itself!). Bad News: I had a pretty strong flare while on the biosimilar and now go back to Enbrel to find out if my RA is better with Enbrel (or if both have lost their efficacy). Price difference – yes, there is, but much less than what I would have expected.
Yes, I would definitely switch, I am guessing at some point most of us will because of insurance. Now wanting to switch and being made it switch that may be two different things.
I live in Canada and have been on Inflectra the biosimilar to Remicade for one year. I had been on Cimzia injections successfully for 4years til Cimzia began losing its efffect and I was declining. The studies and succcess of Inflectra were explained to me in detail by my Doctor and I decided to try it. So far, the results have been successful for me and my symptoms are now back under control. I always research new drugs before introducing them to my body and I was surprised at the length of time Inflectra has successfullly been in use in Europe. I am lucky our health care covers all drugs especially when taking Cimzia as it was approx $3500.00 per month and therefore because the biosimilars are very very much less expensive, the good old drug companies would fight biosimillars as a competitor. Sadly, the patients are not seen as sufffering humans as in the drug industry, we are dollar signs. I hope you do the research and try Inflectra if offered when you need change
Hi there I am starting on Cimzia today was wondering how long it takes to work and if you had any side effects. Thank you very much.
For the most part We won’t have a choice- the insurance companies make that call.
I agree with Laura.
It doesn’t matter two hoots what you or I think.
It will all be controlled by the goverment(s) and
the insurance companies. Unfortunately this is another
disinsentive for drug companies to continue to develop
new biologics which is what we really need done as
one after another biologic loses its effectiveness for us.
Thank you for explaining “biosimilars”. It is a very helpful article.
I noticed “relief” within 8 weeks of taking Cimzia. Swelling decreased in my hands and very little morning stiffness. Had to make the switch from Rituxan which was not slowing the progression. Good luck!
I live in Germany and switched to Benepali, the biosimilar of Enbrel. Good news: I had less skin reaction at the injection point where Enbrel caused itching and reddness, while its biosimilar caused no skin reaction. The conservational fluid might be different (which can be an asset in itself!). Bad News: I had a pretty strong flare while on the biosimilar and now go back to Enbrel to find out if my RA is better with Enbrel (or if both have lost their efficacy). Price difference – yes, there is, but much less than what I would have expected.
I live in Canada and I am about to start “Brenzys” (etanercept) a biosimilar to Enbrel has anyone had any experience with this drug to share? Thankyou